A Bivalent Vaccine Based on a Replication-Incompetent Influenza Virus Protects against Streptococcus pneumoniae and Influenza Virus Infection

A Novel Role for Non-Neutralizing Antibodies against Nucleoprotein in Facilitating Resistance to Influenza Virus

(2014) D. M. Carragher et al.   JOURNAL OF IMMUNOLOGY

Protection against Lethal Influenza with a Viral Mimic

(2013) S. F. Baker et al.   JOURNAL OF VIROLOGY

Pseudotyped Influenza A Virus as a Vaccine for the Induction of Heterotypic Immunity

(2012) T. J. Powell et al.   JOURNAL OF VIROLOGY

A replication-incompetent virus possessing an uncleavable hemagglutinin as an influenza vaccine

(2012) Hiroaki Katsura et al.   VACCINE

Next generation pneumococcal vaccines

(2011) Kristin L Moffitt et al.   CURRENT OPINION IN IMMUNOLOGY

Contributions of Antinucleoprotein IgG to Heterosubtypic Immunity against Influenza Virus

(2011) Mark W. LaMere et al.   JOURNAL OF IMMUNOLOGY

Inactivated and live, attenuated influenza vaccines protect mice against influenza:Streptococcus pyogenes super-infections

(2011) Michael S. Chaussee et al.   VACCINE

Intranasal vaccination with pneumococcal surface protein A plus poly(I:C) protects against secondary pneumococcal pneumonia in mice

(2011) Hirokazu Ezoe et al.   VACCINE

The future of pneumococcal disease prevention

(2011) Gail L. Rodgers et al.   VACCINE

Contribution of Vaccine-Induced Immunity toward either the HA or the NA Component of Influenza Viruses Limits Secondary Bacterial Complications

(2010) V. C. Huber et al.   JOURNAL OF VIROLOGY

Streptococcus pneumoniae Coinfection Is Correlated with the Severity of H1N1 Pandemic Influenza

(2009) Gustavo Palacios et al.   PLoS One

Potential role for mucosally active vaccines against pneumococcal pneumonia

(2009) Kondwani C. Jambo et al.   TRENDS IN MICROBIOLOGY

Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice

(2009) Keita Oma et al.   VACCINE

Optimized Immune Response Elicited by a DNA Vaccine Expressing Pneumococcal Surface Protein A Is Characterized by a Balanced Immunoglobulin G1 (IgG1)/IgG2a Ratio and Proinflammatory Cytokine Production

(2008) D. M. Ferreira et al.   Clinical and Vaccine Immunology

Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza

(2008) Christopher S. Ambrose et al.   Influenza and Other Respiratory Viruses

Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness

(2008) David M. Morens et al.   JOURNAL OF INFECTIOUS DISEASES

The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease

(2008) Aras Kadioglu et al.   NATURE REVIEWS MICROBIOLOGY

Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae

(2007) Martina M. Ochs et al.   MICROBIAL PATHOGENESIS